中國興業控股(00132.HK)擬760萬元出售數安時代5%股權
格隆匯11月30日丨中國興業控股(00132.HK)發佈公告,於2020年11月27日,中創興科(公司間接全資附屬公司)與南海控股(Prize Rich Inc.的控股股東,而Prize Rich Inc.為持有12.23億股公司已發行股份(相當於公司全部已發行股本71.41%)的股東)訂立股權轉讓協議,據此,中創興科已同意出售,而南海控股已同意購買數安時代的5%股權,現金代價為人民幣760萬元。
數安時代為於中國註冊成立的有限責任公司,其股份於全國中小企業股份轉讓系統掛牌(股份代號:871932)。其主要於中國廣東省從事提供電子認證服務。
公司認為出售事項為變現數安時代股權投資增值的機會。出售事項亦將有助提升集團的現金流量及聚焦集團核心業務發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.